• Suppliers
  • External Access
Shareholders

Analyst Recommendations

Broker Update date Recommendation Target Price
Alantra Equities 14/09/2021 Buy 4.90€
Bankinter 29/07/2021 Buy 5.10€
Barclays 19/03/2021 Sell 4.50€
Bestinver Securities 06/10/2021 Buy 5.50€
CaixaBank BPI 07/07/2021 Buy 7.00€
Deutsche Bank 01/10/2021 Hold 4.50€
Exane BNP Paribas 30/09/2021 Buy 5.10€
GVC Gaesco 14/10/2021 Buy 5.10€
Intermoney Valores 08/10/2021 Buy 5.30€
JB Capital Markets 16/06/2021 Hold 5.50€
J.P. Morgan 09/07/2021 Hold 4.50€
Kepler Cheuvreux 23/09/2021 Hold 3.70€
Mirabaud 30/09/2021 Buy 4.29€
Morgan Stanley 24/09/2021 Hold 3.60€
Norbolsa 14/10/2021 Hold 4.50€
Oddo BHF 18/10/2021 Hold 4.00€
Renta 4 27/07/2021 Buy 5.50€
Santander 29/03/2021 Hold 4.95€
UBS 08/10/2021 Buy 5.00€
 


Disclaimer
 

“Gestamp is covered by the analyst firms detailed on this list. This list may not be exhaustive and is also subject to change. It should be noted that any opinion, estimate, or prediction in relation to Gestamp's performance made by the analysts of these companies are exclusively theirs and do not represent the opinions, estimates, or predictions of Gestampl or its management. The fact that it is included on this list or that this information is provided does not imply—and therefore expressly rejects—any type of endorsement or ratification of any type of information, estimate, prediction, or opinion of these analysts. This data—which falls outside of the scope of the mandatory information required by the Spanish National Securities Market Commission—is provided courtesy of the Company due to its utility and for purely informative purposes, and the Company has no intention of endorsing or providing any type of investment-related assessment. Gestamp does not guarantee and has not adopted any measures to verify the accuracy, suitability, or exhaustiveness of the data, and under no circumstance does it assume responsibility for any inaccuracy, omission, or error in this data; in the conclusions drawn therefrom; or for any decision made on the basis of this data or information.
 

The interpretations, estimates, opinions, forecasts, predictions, price targets, hypotheses, conclusions and recommendations, in addition to any non-factual information related to Gestamp's performance analyzed by the Analysts, are exclusively theirs and, therefore, do not represent the interpretations, estimates, opinions, forecasts, predictions, price targets, hypotheses, conclusions, or recommendations of Gestamp or any of its directors or employees. The publication of this list or of information on Analyst coverage, including the estimated results consensus, does not imply any type of endorsement or ratification by Gestamp of the interpretations, estimates, opinions, forecasts, predictions, price targets, hypotheses, conclusions and recommendations of the Analysts. Gestamp does not guarantee and has not adopted any measure to verify the accuracy, suitability, or exhaustiveness of this information, and under no circumstance does it assume responsibility for any inaccuracies, omissions, or errors contained therein; conclusions drawn therefrom; or any decision made based this information. This declaration also applies to the Analysts' obligation to document all circumstances that could reasonably jeopardize the objectivity of their recommendations and, in particular, all the relevant financial interests in the financial securities and instruments that constitute the object of the recommendation or conflicts of interest with the issuer to which the recommendation makes reference.”
 

Investor Relations Contact

Alfonso XII, 16 28014 Madrid